US Food and Drug Association (FDA) through its ‘imports alert’, bans yet another India-based drug manufacturing plant over quality control issues.
Mumbai based Polydrug Laboratories Pvt Ltd’s Ambernath manufacturing plant will be the 10th
site in the country this year against which such action is taken. The same site was banned 2 months back by Canada due to data integrity issues. Europe also took a similar action due to critical deficiencies.
Such moves will slow down India’s growth of $15 million pharmaceutical industry supplying 40 per cent medicines sold in US.
Tagged: United States